T. Rowe Price Associates’s CRH CRH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$224M Sell
2,128,649
-11,922
-0.6% -$1.4M 0.03% 433
2025
Q4
$267M Buy
2,140,571
+1,586,810
+287% +$189M 0.03% 382
2025
Q3
$66.4M Buy
553,761
+37,537
+7% +$3.96M 0.01% 712
2025
Q2
$47.4M Buy
516,224
+13,491
+3% +$1.23M 0.01% 742
2025
Q1
$44.2M Buy
502,733
+35,160
+8% +$3.46M 0.01% 758
2024
Q4
$43.3M Sell
467,573
-54,346
-10% -$5.23M 0.01% 800
2024
Q3
$48.4M Buy
521,919
+5,446
+1% +$457K 0.01% 766
2024
Q2
$38.7M Buy
+516,473
New +$41.2M ﹤0.01% 797
2024
Q1
Sell
-3,458
Closed -$240K 2962
2023
Q4
$240K Buy
+3,458
New +$209K ﹤0.01% 2471

Other funds holding CRH

T. Rowe Price Associates's CRH Position: Q1 2026 in Review

T. Rowe Price Associates reduced its CRH (CRH) stake by 0.56% in Q1 2026, selling an estimated $1.4M and leaving 2,128,649 shares worth $224M. The position accounts for 0.03% of the portfolio, ranked #433.

T. Rowe Price Associates first reported a position in CRH in Q4 2023 and has held it in 9 quarters since. The position peaked at $267M in Q4 2025. 1,006 funds tracked by Wall St. Rank hold CRH as of Q1 2026.

  • T. Rowe Price Associates held 2,128,649 shares of CRH worth $224M as of Q1 2026.
  • T. Rowe Price Associates sold 11,922 CRH shares in Q1 2026, an estimated $1.4M.
  • CRH made up 0.03% of T. Rowe Price Associates's portfolio in Q1 2026, its #433 holding.
  • T. Rowe Price Associates first reported a position in CRH in Q4 2023 and has held it in 9 quarters since.
  • T. Rowe Price Associates's CRH position peaked at $267M in Q4 2025.
  • 1,006 funds tracked by Wall St. Rank held CRH as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.